Stylli Harry 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009
Insider Transaction Report
Form 4
Stylli Harry
Director
Transactions
- Award
Stock Option (right to buy)
2009-05-12+25,000→ 25,000 totalExercise: $3.93From: 2010-05-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option terminates on the earlier of (i) May 12, 2019 or (ii) ninety (90) days afer the reporting person ceases to be a director of the Issuer.